CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 39 filers reported holding CUE BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $308,000 | -49.5% | 20,500 | -17.7% | 0.00% | -66.7% |
| Q2 2020 | $610,000 | +52.5% | 24,900 | -11.7% | 0.00% | +50.0% |
| Q1 2020 | $400,000 | -10.5% | 28,200 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $447,000 | -5.7% | 28,200 | -50.0% | 0.00% | +100.0% |
| Q3 2019 | $474,000 | +253.7% | 56,400 | +276.0% | 0.00% | 0.0% |
| Q2 2019 | $134,000 | +605.3% | 15,000 | +500.0% | 0.00% | – |
| Q1 2019 | $19,000 | +72.7% | 2,500 | 0.0% | 0.00% | – |
| Q4 2018 | $11,000 | -50.0% | 2,500 | 0.0% | 0.00% | – |
| Q3 2018 | $22,000 | -24.1% | 2,500 | 0.0% | 0.00% | – |
| Q2 2018 | $29,000 | -17.1% | 2,500 | 0.0% | 0.00% | – |
| Q1 2018 | $35,000 | – | 2,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,510,282 | $7,370,000 | 4.76% |
| SANDERS MORRIS HARRIS LLC | 873,021 | $4,261,000 | 0.83% |
| P.A.W. CAPITAL CORP | 150,000 | $732,000 | 0.76% |
| Nantahala Capital Management | 2,244,359 | $10,952,000 | 0.48% |
| Bleichroeder LP | 552,000 | $2,694,000 | 0.48% |
| APOGEM CAPITAL LLC | 111,259 | $543,000 | 0.37% |
| Slate Path Capital LP | 1,483,619 | $7,240,000 | 0.37% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $2,335,000 | 0.20% |
| CARLSON CAPITAL L P | 405,000 | $1,976,000 | 0.14% |
| Bridgefront Capital, LLC | 19,968 | $97,000 | 0.12% |